HCM – hutchmed (china) limited - american depositary shares (US:NASDAQ)

News

HUTCHMED H2 Earnings Call Highlights [Yahoo! Finance]
HUTCHMED Reports 2025 Full Year Results and Business Updates
HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors
HUTCHMED to Announce 2025 Final Results
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com